358. Comparison of Voriconazole (VORI), Isavuconazole (ISAV), and Posaconazole (POSA) in the Initial Treatment of Patients With Invasive Aspergillosis (IA)

BACKGROUND: While VORI is recommend as first-line therapy for patients with IA, ISAV, and POSA have been approved for the treatment and prophylaxis of IA, respectively. We evaluated treatment responses among patients with IA receiving triazole antifungals. METHODS: We performed a retrospective cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Matthew P, Orejas, José Luis, Arbona-Haddad, Esther, Marty, Francisco M, Koo, Sophia, Hammond, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255647/
http://dx.doi.org/10.1093/ofid/ofy210.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255647/
http://dx.doi.org/10.1093/ofid/ofy210.369

Ejemplares similares